COST-EFFECTIVENESS ANALYSIS OF AN ADJUSTED POLYGENIC RISK SCORE IN CARDIOVASCULAR DISEASE PREVENTION

被引：0
|
作者：
Hatziandreou, E. [1 ]
Panagiotou, N. [1 ]
机构：
[1] IDNA Genom, Attica, Greece
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE159
引用
收藏
页码：S81 / S81
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of implementing polygenic risk score in a workplace cardiovascular disease prevention program
    Mujwara, Deo
    Kintzle, Jen
    Di Domenico, Paolo
    Busby, George B.
    Botta, Giordano
    [J]. FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [2] Cost-Effectiveness of Polygenic Risk Scores to Guide Statin Therapy for Cardiovascular Disease Prevention
    Kiflen, Michel
    Le, Ann
    Mao, Shihong
    Lali, Ricky
    Narula, Sukrit
    Xie, Feng
    Pare, Guillaume
    [J]. CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2022, 15 (05): : 386 - 395
  • [3] ADJUSTED POLYGENIC RISK SCORE ENABLES PERSONALIZED CARDIOVASCULAR DISEASE PREVENTION AND CLINICAL MANAGEMENT
    Panagiotou, N.
    Chatziandreou, E.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S378 - S379
  • [4] Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis
    Tolla, Mieraf Taddesse
    Norheim, Ole Frithjof
    Memirie, Solomon Tessema
    Abdisa, Senbeta Guteta
    Ababulgu, Awel
    Jerene, Degu
    Bertram, Melanie
    Strand, Kirsten
    Verguet, Stephane
    Johansson, Kjell Arne
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2016, 14
  • [5] Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis
    Mieraf Taddesse Tolla
    Ole Frithjof Norheim
    Solomon Tessema Memirie
    Senbeta Guteta Abdisa
    Awel Ababulgu
    Degu Jerene
    Melanie Bertram
    Kirsten Strand
    Stéphane Verguet
    Kjell Arne Johansson
    [J]. Cost Effectiveness and Resource Allocation, 14
  • [6] Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease
    Ferket, Bart S.
    Hunink, M. G. Myriam
    Khanji, Mohammed
    Agarwal, Isha
    Fleischmann, Kirsten E.
    Petersen, Steffen E.
    [J]. HEART, 2017, 103 (07) : 491 - 499
  • [7] Cost-Effectiveness Analysis of the Polypill Approach vs Periodic Risk Assessment for Prevention of Cardiovascular Disease
    Ferket, Bart S.
    Hunink, Myriam
    Khanji, Mohammed
    Agarwal, Isha
    Fleischmann, Kirsten E.
    Petersen, Steffen E.
    [J]. CIRCULATION, 2016, 134
  • [8] Smoking cessation for primary prevention of cardiovascular disease: A cost-effectiveness analysis
    Kinderen, AJD
    Oh, F
    De Laet, C
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 692 - 693
  • [9] Cost-Effectiveness Analysis of the Polypill Approach vs Periodic Risk Assessment for Prevention of Cardiovascular Disease
    Ferket, Bart S.
    Hunink, Myriam
    Khanji, Mohammed
    Agarwal, Isha
    Fleischmann, Kirsten E.
    Petersen, Steffen E.
    [J]. CIRCULATION, 2016, 134
  • [10] Towards Effective Cost-Effectiveness Analysis in Atherosclerotic Cardiovascular Disease Prevention
    Kajinami, Kouji
    [J]. CIRCULATION JOURNAL, 2018, 82 (04) : 954 - 955
12345